Stephen Pandol to Cisplatin
This is a "connection" page, showing publications Stephen Pandol has written about Cisplatin.
Connection Strength
0.091
-
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models. BMC Cancer. 2023 Jun 02; 23(1):499.
Score: 0.050
-
Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model. Gynecol Oncol. 2020 10; 159(1):277-284.
Score: 0.041